Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based Proteochemometrics
暂无分享,去创建一个
[1] T. Lundstedt,et al. PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. , 2001, Biochimica et biophysica acta.
[2] Heng Tao Shen,et al. Principal Component Analysis , 2009, Encyclopedia of Biometrics.
[3] Peteris Prusis,et al. Proteochemometric modeling of HIV protease susceptibility , 2008, BMC Bioinformatics.
[4] B. Kowalski,et al. Partial least-squares regression: a tutorial , 1986 .
[5] Z. R. Li,et al. Update of PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..
[6] I. Melnikova,et al. Targeting protein kinases , 2004, Nature Reviews Drug Discovery.
[7] Woody Sherman,et al. ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..
[8] Erik Johansson,et al. GIFI‐PLS: Modeling of Non‐Linearities and Discontinuities in QSAR , 2000 .
[9] P. Prusis,et al. Proteochemometric modelling of antibody-antigen interactions using SPOT synthesised peptide arrays. , 2007, Protein engineering, design & selection : PEDS.
[10] Jarl E. S. Wikberg,et al. Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors , 2008, J. Chem. Inf. Model..
[11] L. Jiang,et al. PROFEAT: a web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence , 2006, Nucleic Acids Res..
[12] Gerard J. P. van Westen,et al. Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets , 2011 .
[13] Ping Chen,et al. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase in , 2006, Journal of medicinal chemistry.
[14] Peteris Prusis,et al. Proteochemometrics: A Tool for Modeling the Molecular Interaction Space , 2005 .
[15] K. Fidelis,et al. Generalized modeling of enzyme–ligand interactions using proteochemometrics and local protein substructures , 2006, Proteins.
[16] R. Morphy. Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.
[17] P. Hajduk,et al. Navigating the kinome. , 2011, Nature chemical biology.
[18] Mindy I. Davis,et al. Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.
[19] H. Matter,et al. Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. , 2002, Journal of medicinal chemistry.
[20] Maurizio Vichi,et al. Studies in Classification Data Analysis and knowledge Organization , 2011 .
[21] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[22] Irini A. Doytchinova,et al. EpiTOP - a proteochemometric tool for MHC class II binding prediction , 2010, Bioinform..
[23] P. Changelian,et al. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. , 2008, European journal of pharmacology.
[24] Peteris Prusis,et al. Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions , 2005, Bioinform..
[25] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[26] Didier Rognan,et al. Enhancing the Accuracy of Chemogenomic Models with a Three-Dimensional Binding Site Kernel , 2011, J. Chem. Inf. Model..
[27] G. Wohlfahrt,et al. Field‐based comparison of ligand and coactivator binding sites of nuclear receptors , 2009, Biopolymers.
[28] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[29] Mindy I. Davis,et al. A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.
[30] Christoph Steinbeck,et al. Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials. , 2006, Journal of molecular graphics & modelling.
[31] P. Prusis,et al. Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. , 2008, Bioorganic & medicinal chemistry.
[32] G. Scapin. Protein kinase inhibition: different approaches to selective inhibitor design. , 2006, Current drug targets.
[33] Joost C. M. Uitdehaag,et al. A theoretical entropy score as a single value to express inhibitor selectivity , 2011, BMC Bioinformatics.
[34] P. Bamborough. System-based drug discovery within the human kinome , 2012, Expert opinion on drug discovery.
[35] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[36] E. Casale,et al. Through the "gatekeeper door": exploiting the active kinase conformation. , 2010, Journal of medicinal chemistry.
[37] D. Flower,et al. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. , 2010, European journal of medicinal chemistry.
[38] W. Sherman,et al. Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters , 2010, ChemMedChem.
[39] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[40] T. Lundstedt,et al. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.
[41] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[42] Shandar Ahmad,et al. Proteochemometric Recognition of Stable Kinase Inhibition Complexes Using Topological Autocorrelation and Support Vector Machines , 2010, J. Chem. Inf. Model..
[43] Weida Tong,et al. Mold2, Molecular Descriptors from 2D Structures for Chemoinformatics and Toxicoinformatics , 2008, J. Chem. Inf. Model..
[44] G. V. van Westen,et al. Structure-Based Identification of OATP1B1/3 Inhibitors , 2013, Molecular Pharmacology.
[45] Thorsten Meinl,et al. KNIME: The Konstanz Information Miner , 2007, GfKl.
[46] J. Topliss,et al. Chance correlations in structure-activity studies using multiple regression analysis , 1972 .
[47] James R Kiefer,et al. Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6. , 2010, Journal of molecular biology.
[48] Jarl E. S. Wikberg,et al. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques , 2010, BMC Bioinformatics.